Endotoxemia
Information
- Disease name
- Endotoxemia
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05318183 | Active, not recruiting | N/A | Assessing Gut Microbiota Mediated Health Outcomes of Whole Wheat and Its Major Bioactive Components | January 27, 2022 | December 2025 |
| NCT00185003 | Completed | Phase 1 | Blockade of Vascular Potassium Channels During Human Endotoxemia | January 2003 | June 2005 |
| NCT00246714 | Completed | Phase 1 | Pathophysiology and Clinical Relevance of Endotoxin Tolerance in Humans | October 2005 | December 2007 |
| NCT00284869 | Completed | Phase 1 | Ethnic Differences in the Inflammatory Response in Systemic Inflammation | January 2006 | April 2006 |
| NCT00309374 | Completed | Phase 1 | Anti-Inflammatory Effect of Statins in the Human Endotoxin Model | March 2006 | July 2006 |
| NCT00332267 | Completed | N/A | Cerebral Blood Flow and Metabolism During Hypoxia and Endotoxemia | May 2006 | July 2006 |
| NCT00412906 | Completed | N/A | Study of Gene Activity in Fat and Muscle in Diabetics and Healthy Controls | November 2006 | April 2008 |
| NCT00785018 | Completed | N/A | In Vivo Effects of C1-esterase Inhibitor on the Innate Immune Response During Human Endotoxemia | November 2008 | August 2009 |
| NCT03973996 | Completed | N/A | Gut-level Antiinflammatory Activities of Green Tea in Metabolic Syndrome | July 1, 2019 | March 1, 2021 |
| NCT04019457 | Completed | N/A | Cereals and Intestinal Function | August 1, 2018 | February 28, 2020 |
| NCT04037722 | Completed | N/A | Echocardiographic Changes After 3-hydroxy Butyrate+Whey Intake | June 17, 2019 | January 23, 2020 |
| NCT04056286 | Completed | N/A | Gastro-intestinal and Hormonal Responses to Systemic Inflammatory Disease | June 17, 2019 | January 23, 2020 |
| NCT04064268 | Completed | N/A | Anabolic Potential of 3-hydroxybutyrate (3-OHB) and Whey Protein in a Human Catabolic Inflammatory Disease Model | June 17, 2019 | January 23, 2020 |
| NCT04117802 | Completed | N/A | Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome | September 3, 2019 | December 1, 2021 |
| NCT04130321 | Completed | N/A | Demonstration of the Prebiotic-like Effects of Camu-camu Consumption Against Obesity-related Disorders in Humans | October 31, 2020 | April 21, 2022 |
| NCT04788680 | Completed | N/A | Effects of Non-calorie Sweeteners, Mono- and Disaccharides on Intestinal Barrier Function | March 1, 2021 | December 31, 2022 |
| NCT05752968 | Completed | Elevated Levels of Antibodies to Endotoxin Core in Hemodialysis Patients With Peripheral Artery Disease | May 3, 2023 | December 31, 2023 | |
| NCT05776329 | Completed | N/A | Dietary Intervention to Reduce Metabolic Endotoxemia | April 14, 2023 | January 30, 2024 |
| NCT00513110 | Completed | Phase 1 | A Possible Therapeutic Role for Adenosine During Inflammation | August 2007 | August 2008 |
| NCT00783068 | Completed | N/A | Anti-inflammatory Effects of GTS-21 After LPS | August 2008 | August 2010 |
| NCT00184990 | Completed | Phase 1 | Effect of Selective iNOS Inhibition During Human Endotoxemia | January 2005 | September 2005 |
| NCT00916448 | Completed | N/A | The Effects of Atazanavir-induced Hyperbilirubinemia During Human Endotoxemia | May 2009 | July 2015 |
| NCT01046669 | Completed | N/A | Safety and Efficacy of Polymyxin B Hemoperfusion (PMX) for Septic Shock | June 2010 | June 2017 |
| NCT01091571 | Completed | Phase 4 | The Effects of Oral Dipyridamole Treatment on the Innate Immune Response During Human Endotoxemia | March 2010 | October 2010 |
| NCT01100996 | Completed | N/A | Anti-inflammatory Effects of Enriched Enteral Nutrition During Human Experimental Endotoxemia | February 2010 | April 2011 |
| NCT01374711 | Completed | N/A | The Effects of Immunostimulation With GM-CSF or IFN-y on Immunoparalysis Following Human Endotoxemia | May 2011 | November 2011 |
| NCT01474629 | Completed | N/A | Probiotic Sport Study | October 2011 | September 2012 |
| NCT01766414 | Completed | Phase 3 | In Vivo Effects of C1-esterase Inhibitor on the Innate Immune Response During Human Endotoxemia - VECTOR II | September 2013 | January 2014 |
| NCT02127749 | Completed | N/A | The Role of the Gut Microbiota in the Systemic Immune Response During Human Endotoxemia | June 2014 | December 2015 |
| NCT02521779 | Completed | N/A | The Role of Dietary Fat on Postprandial Endotoxemia in Healthy Adults | April 2014 | April 2015 |
| NCT02612480 | Completed | N/A | Ticagrelor in Human Endotoxemia Response to Human Endotoxemia | October 2015 | December 2015 |
| NCT02629874 | Completed | Phase 1 | PK/PD of EA-230 During Endotoxemia | February 2015 | December 2015 |
| NCT02675868 | Completed | Phase 4 | Effects of Vasopressors on Immune Response | January 2016 | October 2016 |
| NCT02876601 | Completed | Phase 4 | Defibrotide in the Human Endotoxemia Model --- an Exploratory Trial Investigating the Effects and the Mechanisms of Defibrotide | April 18, 2017 | February 12, 2018 |
| NCT02922673 | Completed | N/A | The Effects of Acetylsalicylic Acid on Immunoparalysis Following Human Endotoxemia | September 2016 | September 2017 |
| NCT03158363 | Completed | N/A | A New Model of Acute Febrile Disease | June 1, 2017 | August 31, 2017 |
| NCT03240497 | Completed | N/A | Effects of Cold Exposure and Breathing Techniques on Immune Response | April 12, 2016 | April 2018 |
| NCT03319550 | Completed | N/A | Whey vs Casein to Combat Post-inflammatory Protein and Muscle Waste in Acute Disease | December 7, 2017 | September 19, 2018 |
| NCT03482284 | Completed | N/A | Effect of Monosaccharides on Intestinal Barrier Function | May 20, 2016 | August 1, 2018 |
| NCT03754504 | Completed | N/A | Effects of Cranberry Powder Supplements on Gut Microbiota Diversity and Metabolic Syndrome | October 15, 2018 | March 1, 2020 |
| NCT03800277 | Completed | N/A | Effect of Cranberry and Agaves Extract on Microbiota and Intestinal Health | November 5, 2018 | December 31, 2021 |
| NCT03972878 | Completed | N/A | Foodprint 1.0: Physiological Acute Responses After Consumption of Confectionary Products | March 22, 2019 | December 31, 2020 |
| NCT04352985 | No longer available | Evaluating the Use of Polymyxin B Cartridge Hemoperfusion for Patients With Septic Shock and COVID 19 | |||
| NCT06147440 | Recruiting | N/A | Different Dietary Patterns | October 20, 2023 | October 2024 |
| NCT06203015 | Recruiting | The Relations Among Endotoxin, Inflammatory Cytokines, Cognitive Markers and Brain MRI Changes in Subjects With Depressive Disorder | June 1, 2022 | June 1, 2024 | |
| NCT03901807 | Recruiting | N/A | Safety and Efficacy of Polymyxin B Hemoperfusion (PMX) for Endotoxemic Septic Shock in a Randomized, Open-Label Study | October 17, 2019 | September 30, 2025 |
| NCT02825329 | Temporarily not available | Open-label Evaluation of Polymyxin B Hemoperfusion for Septic Shock | |||
| NCT00197899 | Unknown status | N/A | Low-Dose Endotoxemia and the Acute Phase Response | March 2004 | January 2005 |
| NCT03624569 | Unknown status | N/A | Cardiometabolic Benefits of Potatoes Mediated Along the Gut-Vessel Axis in Adults With Metabolic Syndrome | August 15, 2018 | July 2020 |
| NCT03413735 | Unknown status | N/A | Dietary Green Tea Confection For Resolving Gut Permeability-Induced Metabolic Endotoxemia In Obese Adults | August 29, 2018 | March 30, 2023 |
| NCT00413465 | Unknown status | N/A | Study of Renal Blood Flow During Human Endotoxemia | November 2006 | December 2007 |
| NCT00413348 | Unknown status | N/A | Type 2 Diabetes and the Effect of Probiotics | November 2006 | December 2007 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D019446